On Campus

Changing the ethical culture of pharma

Changing the ethical culture of pharma

The last five years, said Arthur Caplan, Ph.D., have seen the demonization of the pharmaceutical industry. Conflicts of interest, censored scientists, flawed drugs and devices placed on the market, and the failure to protect subjects of clinical trials, have been “flat-out ethical disasters,” said Caplan, chair of the Department of Medical Ethics at the University of Pennsylvania School of Medicine.Nevertheless, he told an audience at the School of Management in September, this demonization is irresponsible. “The pharmaceutical industry is not the tobacco industry,” he said. “The pharmaceutical industry produces medicines that relieve pain,...

Read more...

An ongoing disaster stemming from neglect

An ongoing disaster stemming from neglect

For Roberto Johansson, M.D., Ph.D., Hurricane Katrina was a disaster that didn’t have to happen....

Read more...

Tracing the history of medical education

Tracing the history of medical education

In the mid-19th century, medical schools were faculty-owned, for-profit operations that churned out...

Read more...

Baboons, humans and stress: the cost of being an SOB

Baboons, humans and stress: the cost of being an SOB

Baboons in Africa’s Serengeti Plain spend just three hours a day finding food, said Robert...

Read more...


 
 
Download on the Apple App Store